Here’s why we must continue to study Kratom and other opioid-like drugs

BY PAULA N. BROWN, OPINION CONTRIBUTOR — 07/07/18 04:00 PM EDT 36 THE VIEWS EXPRESSED BY CONTRIBUTORS ARE THEIR OWN AND NOT THE VIEW OF THE HILL The U.S. Food and Drug Administration (FDA) recently gave final approval for the first non-opioid drug shown to lessen the severity of opioid withdrawal symptoms. Meanwhile, President Trump signed into law groundbreaking …

Here’s why we must continue to study Kratom and other opioid-like drugs Read More »